Physician profile
Jeffrey E Kleiman
NPI 1093729592
$1,077.71
in general payments reported to CMS, 2019-2025
25 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $143 · 2021: $49.28 · 2022: $29.17 · 2023: $84.93 · 2024: $236 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $130.37 | 2020-2025 | Cmf |
| Collegium Pharmaceutical, INC. | $121.23 | 2025 | Xtampza |
| Amgen INC. | $119.39 | 2024 | Krystexxa |
| Bioventus LLC | $98.50 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Ermi LLC | $68.43 | 2019 | |
| Acumed LLC | $55.29 | 2025 | Acumed |
| Si-Bone, INC. | $55.26 | 2019 | |
| Polymedics Innovations INC. | $54.53 | 2024 | |
| Zimmer Biomet Holdings, INC. | $40.61 | 2020 | |
| Orthofix Medical, INC. | $39.95 | 2024-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $35.34 | 2025 | |
| Organogenesis INC. | $32.95 | 2023 | Puraply |
| Nevro Corp. | $29.17 | 2022 | |
| Medtronic, INC. | $24.98 | 2025 | Inceptiv |
| Pacira Pharmaceuticals Incorporated | $24.31 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.77 | 2023 | Krystexxa |
| Pacira Therapeutics, INC. | $18.57 | 2020 | |
| Inari Medical, INC. | $17.03 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Coastal Medical Technologies LLC | $16.80 | 2023 | |
| Smith+Nephew, INC. | $16.41 | 2023 | Collagenase Santyl, Regranex |
| Endo Pharmaceuticals INC. | $15.64 | 2021 | |
| Fidia Pharma USA INC. | $13.06 | 2020 | |
| Zyla Life Sciences, INC. | $12.11 | 2019 | |
| Heraeus Medical, LLC. | $9.68 | 2020 | |
| Kerecis Limited | $9.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kleiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.